{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:40:54Z","timestamp":1774928454618,"version":"3.50.1"},"reference-count":25,"publisher":"Cambridge University Press (CUP)","issue":"6","license":[{"start":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T00:00:00Z","timestamp":1482192000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["www.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Cardiol Young"],"published-print":{"date-parts":[[2017,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Different treatment options for pulmonary hypertension have emerged in recent years, and evidence-based management strategies have improved quality of life and survival in adults. In children with pulmonary vascular disease, therapeutic algorithms are not so clearly defined; this study determined current treatment initiation in children with pulmonary hypertension in participating centres of a registry.<\/jats:p><jats:p>Through the multinational Tracking Outcomes and Practice in Pediatric Pulmonary Hypertension registry, patient demographics, diagnosis, and treatment as judged and executed by the local physician were collected. Inclusion criteria were &gt;3 months and &lt;18 years of age and diagnostic cardiac catheterisation consistent with pulmonary hypertension (mean pulmonary arterial pressure \u2a7e25 mmHg, pulmonary vascular resistance index \u2a7e3 Wood units\u00d7m<jats:sup>2<\/jats:sup>, and mean pulmonary capillary wedge pressure \u2a7d12 mmHg).<\/jats:p><jats:p>At diagnostic catheterisation, 217\/244 patients (88.9%) were treatment na\u00efve for pulmonary hypertension-targeted therapy. Targeted therapy was initiated after catheterisation in 170 (78.3%) treatment-na\u00efve patients. A total of 19 patients received supportive therapy, 28 patients were not started on therapy, and 26 patients (10.7%) were on targeted treatment before catheterisation. Among treatment-na\u00efve subjects, treatment was initiated with one targeted drug (n=112, 51.6%), dual therapy (n=39, 18%) or triple-therapy (n=5, 2.3%), and calcium channel blockers with one targeted medication in one patient (0.5%). Phosphodiesterase inhibitors type 5 were used frequently; some patients with pulmonary hypertension related to lung disease received targeted therapy.<\/jats:p><jats:p>There is a diverse therapeutic approach for children with pulmonary hypertension with a need of better-defined treatment algorithms based on paediatric consensus for different aetiologies including the best possible diagnostic workup.<\/jats:p>","DOI":"10.1017\/s1047951116002493","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T12:53:12Z","timestamp":1482238392000},"page":"1123-1132","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":13,"title":["Treatment initiation in paediatric pulmonary hypertension: insights from a multinational registry"],"prefix":"10.1017","volume":"27","author":[{"given":"Tilman","family":"Humpl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rolf M. F.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric D.","family":"Austin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margrit S.","family":"Fasnacht Boillat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Damien","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dunbar D.","family":"Ivy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malgorzata","family":"Zuk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurice","family":"Beghetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ingram","family":"Schulze-Neick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"S1047951116002493_ref25","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00140112"},{"key":"S1047951116002493_ref15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.04.00028404"},{"key":"S1047951116002493_ref7","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.016667"},{"key":"S1047951116002493_ref12","doi-asserted-by":"crossref","unstructured":"Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland. Thorax 2008; 63 (Suppl 2): ii1\u2013ii41.","DOI":"10.1136\/thx.2007.090480"},{"key":"S1047951116002493_ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2009.07.033"},{"key":"S1047951116002493_ref4","doi-asserted-by":"publisher","DOI":"10.1016\/S0009-9236(03)00005-5"},{"key":"S1047951116002493_ref10","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201406-1052OC"},{"key":"S1047951116002493_ref17","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.026591"},{"key":"S1047951116002493_ref22","doi-asserted-by":"publisher","DOI":"10.2165\/11539190-000000000-00000"},{"key":"S1047951116002493_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2004.02.037"},{"key":"S1047951116002493_ref24","unstructured":"www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAltersforHumanMedicalProducts\/usm391152.htm."},{"key":"S1047951116002493_ref6","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.104.473371"},{"key":"S1047951116002493_ref23","unstructured":"www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm317743.htm."},{"key":"S1047951116002493_ref5","doi-asserted-by":"publisher","DOI":"10.1203\/PDR.0b013e318179954c"},{"key":"S1047951116002493_ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.10.028"},{"key":"S1047951116002493_ref3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.05.00075305"},{"key":"S1047951116002493_ref2","doi-asserted-by":"publisher","DOI":"10.1378\/chest.10-0969"},{"key":"S1047951116002493_ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61621-8"},{"key":"S1047951116002493_ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2011.11.002"},{"key":"S1047951116002493_ref8","doi-asserted-by":"publisher","DOI":"10.4103\/2045-8932.83456"},{"key":"S1047951116002493_ref18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.114.3.787"},{"key":"S1047951116002493_ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.004526"},{"key":"S1047951116002493_ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2010.06.010"},{"key":"S1047951116002493_ref19","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1183\/09031936.00139009","article-title":"Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"34","author":"Galie","year":"2009","journal-title":"Eur Respir J"},{"key":"S1047951116002493_ref20","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.70.4.580"}],"container-title":["Cardiology in the Young"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S1047951116002493","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,16]],"date-time":"2019-09-16T19:25:56Z","timestamp":1568661956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S1047951116002493\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S1047951116002493"],"URL":"https:\/\/doi.org\/10.1017\/s1047951116002493","relation":{},"ISSN":["1047-9511","1467-1107"],"issn-type":[{"value":"1047-9511","type":"print"},{"value":"1467-1107","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]},"assertion":[{"value":"\u00a9 Cambridge University Press 2016\u00a0","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}